LATOYA WOODS-WILLIAMS: Open Payments
NPI 1689180416 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 24 payments from 12 companies in 2025. Trend: 2023 $595 · 2024 $618 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $115 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| Amgen Inc. | 4 | $69 |
| Astellas Pharma US Inc | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Novo Nordisk Inc | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: Auvelity, VERQUVO, Veozah, KEVEYIS, OTEZLA, REXULTI, Ozempic, Kerendia.
Industry payments across FL — which companies pay providers there.
